PD-1 anticorps (C-Term)
Aperçu rapide pour PD-1 anticorps (C-Term) (ABIN500457)
Antigène
Voir toutes PD-1 (PDCD1) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- This antibody detects CD279 / PD1 at C-term.
-
Purification
- Peptide Affinity Chromatography
-
Immunogène
- PD-1 antibody was raised against a 16 amino acid peptide from near the carboxy terminus of Human PD-1.
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
ELISA. Western blot: 0.5 - 1 μg/mL. Immunohistochemistry on paraffin sections.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- Store the antibody at 2-8 °C
-
-
- PD-1 (PDCD1) (Programmed Cell Death 1 (PDCD1))
-
Autre désignation
- CD279 / PD1
-
Sujet
- Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antig en-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of Synonyms: PDCD1, Programmed cell death protein 1, Protein PD-1, hPD-1
-
ID gène
- 5133
-
UniProt
- Q15116
-
Pathways
- Cancer Immune Checkpoints
Antigène
-